Brasília – Health-related judicial actions continue to climb in Brazil, with over 383,000 new cases filed by July 2025—more than 60,000 alone in July—according to the National Council of Justice (CNJ). Such lawsuits account for about 33% of Brazil’s medication spending, amounting to approximately R$3.2 billion in 2024 by the Ministry of Health.
Futuro da Saúde

Despite stricter criteria defined by the Supreme Federal Court (STF) in October—requiring that medications be incorporated by Conitec and backed by scientific evidence—measurable reductions in litigation have not yet materialized.
Futuro da Saúde

Both executive and judicial branches are advocating reforms to tackle excessive judicialization. Proposed measures include better alignment among drug registration, pricing, and incorporation processes, as well as mechanisms to curb abusive litigation—when legal action is used as a commercial strategy to introduce ultra-high-cost drugs into the system.

Source: Futuro da Saúde

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com